Apollomics, Inc. (APLM) Balance Sheet

NASDAQ: APLMAssets, liabilities, debt and equity over 7 years.

APLM balance sheet, 2025

December 31, 2025 · U.S. dollars

$6.7M assets = $9.9M liabilities + −$3.2M equity

What it owns$6.7MCash & ST investments: $3.3M (48.8%)Cash & ST investments$3.3M · 49%Receivables: $2.5M (37.1%)Receivables$2.5M · 37%Other current: $285,000 (4.2%)PP&E: $580,000 (8.6%)PP&E $580,000Other non-current: $83,000 (1.2%)=How it is financed$9.9MCurrent liabilities: $6.3M (63.9%)Current liabilities$6.3M · 64%Other LT liabilities: $3.6M (36.1%)Other LT liabilities$3.6M · 36%

Liabilities exceed assets: shareholders’ equity is negative (−$3.2M).

Both columns are drawn to the same scale: what APLM owns equals what it owes plus shareholders’ equity. Hover a block for its value.

APLM financial health

Current ratio0.96
Tight · current assets cover current liabilities 0.96×
Equity / assets−47.5%
Thin equity · of assets funded by shareholders
Cash / debt509.5%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

APLM balance sheet trends, 2019–2025

Apollomics, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$79.1M2019$6.7M2025−33.7%/yr
Total liabilities$139.8M2019$9.9M2025−35.7%/yr
Shareholders’ equity−$60.7M2019−$3.2M2025—
Cash & short-term investments$74.1M2019$3.3M2025−40.5%/yr
Total debt$136.0M2019$643,0002025−59.0%/yr
Net cash (debt)−$61.8M2019$2.6M2025+$64.5M
Working capital$70.9M2019−$275,0002025−$71.1M
Book value per share−$69.962019−$2.212025—
Current ratio16.4820190.962025−15.52
Debt / equity0.1120230.202024+0.09
Shares outstanding868K20191.4M2025+8.9%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

APLM assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

APLM liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

APLM debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

APLM balance sheet

Apollomics, Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$3.3M$9.8M$37.8M$54.6M$94.5M$154.4M$74.1M
Cash & equivalents$3.3M$9.8M$32.1M$32.7M$46.7M$130.6M$38.5M
Short-term investments—$14,000$5.8M$21.9M$47.7M$23.7M$35.6M
Receivables$2.5M$127,000$466,000$547,000$506,000$415,000$361,000
Inventory$0$0−$466,000$0$2.3M$950,000$0
Other current assets$285,000$374,000$2.1M$629,000$2.1M$959,000$949,000
Total current assets$6.1M$10.3M$39.9M$55.8M$99.4M$156.7M$75.4M
Property, plant & equipment (net)$580,000$1.0M$586,000$1.5M$1.3M$1.9M$2.0M
Goodwill & intangible assets$0$1.7M$14.8M$14.8M$14.8M$10.3M$1.3M
Long-term investments$0$0$0$4.3M$7.8M$0$0
Other non-current assets$83,000$75,000$119,000$124,000$113,000$1.0M$274,000
Total assets$6.7M$13.1M$55.4M$76.5M$123.4M$169.9M$79.1M
Liabilities
Short-term debt$209,000$233,000$4.4M$614,000$2.7M$3.8M$768,000
Total current liabilities$6.3M$7.4M$13.6M$12.4M$13.6M$12.1M$4.6M
Long-term debt$0$0$0$0$0$0$0
Lease obligations$643,000$966,000$425,000$991,000$1.0M$1.5M—
Other long-term liabilities$3.6M$835,000$597,000$512.2M$322.7M$285.8M$135.2M
Total liabilities$9.9M$8.2M$14.2M$524.6M$336.3M$297.9M$139.8M
Shareholders' equity
Common stock & paid-in capital$21,000$11,000$9,000$41,000$40,000$39,000$36,000
Retained earnings (deficit)−$711.8M−$700.8M−$647.0M−$474.6M−$235.4M−$141.5M−$66.7M
Accumulated other comprehensive income$3.4M$3.4M$26.7M$3.4M$12.3M$5.1M$251,000
Total shareholders' equity−$3.2M$4.9M$41.2M−$448.1M−$212.9M−$127.9M−$60.7M
Key figures
Total debt$643,000$966,000$4.7M$991,000$325.4M$289.6M$136.0M
Net cash (debt)$2.6M$8.8M$33.2M$53.6M−$230.9M−$135.2M−$61.8M
Working capital−$275,000$2.9M$26.4M$43.4M$85.8M$144.6M$70.9M
Tangible book value−$3.2M$3.1M$26.5M−$462.9M−$227.7M−$138.3M−$62.1M
Book value per share−$2.21$5.25$55.42−$516.29−$245.24−$147.40−$69.96
Shares outstanding1.4M926K744K868K868K868K868K
Current ratio0.961.392.954.517.3312.9716.48
Quick ratio0.911.342.824.467.0112.8116.27
Debt / equity—0.200.11————
Equity / assets−47.5%37.1%74.4%−586.0%−172.4%−75.3%−76.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 24, 2026); data from EODHD.

APLM financial position

At the end of fiscal 2025 (December 31, 2025), Apollomics had total assets of $6.7 million (down 48.7% from a year earlier), total liabilities of $9.9 million and shareholders' equity of -$3.2 million. It held $3.3 million in cash and short-term investments against $0.6 million of debt, a net cash position of $2.6 million. Its current ratio was 0.96. In the latest quarter (ended March 31, 2026) total assets were $6.7 million and equity -$3.2 million.

Related: APLM income statement, APLM cash flow statement, APLM key metrics. See the APLM stock overview for the latest quote and news.

APLM balance sheet FAQ

What are Apollomics's total assets?

Apollomics reported total assets of $6.7 million at the end of fiscal 2025 (December 31, 2025), compared with $13.1 million a year earlier.

How much debt does Apollomics have?

Apollomics had $0.6 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does Apollomics have?

Apollomics held $3.3 million in cash and short-term investments at the end of fiscal 2025; with $0.6 million of debt that is net cash of $2.6 million.

What is Apollomics's book value?

Apollomics's shareholders' equity (book value) was -$3.2 million at the end of fiscal 2025, or −$2.21 per share.

What is Apollomics's current ratio?

Apollomics had current assets of $6.1 million and current liabilities of $6.3 million, a current ratio of 0.96 (current liabilities exceed current assets).

Biotechnology: balance sheet